• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

AXA Framlington Biotech Fund Z Acc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderAXA Investment Managers UK Ltd
Fund SummaryThe aim of this Fund is to provide long-term capital growth.
SEDOL codeB784NS1
Fund codeFMBTA
ManagersLinden Thomson, Dani Saurymper
Manager Tenure8 years
Morningstar CategorySector Equity Biotechnology
IMA SectorSpecialist
Fund Size£463 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.82%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£4.3950
Buy Price£4.3950
Price Change-0.633%
Price Date25th September 2020
YieldCurrently unavailable
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date29th May 2013
Fund StatusOPEN

3-year Mean Monthly Return: 0.845%

Annual Returns2019201820172016201520142013201220112010
Fund Performance+33.23%+1.05%+7.85%+27.17%-21.98%+56.18%+33.86%+40.87%+22.02%+23.29%
Benchmark Performance
(Sector Equity Biotechnology)
Time PeriodCumulativeBenchmark Performance
(Sector Equity Biotechnology)
Fund Compared to Benchmark
1 day-0.63%+16.08%-16.71%
1 week-1.17%+3.23%-4.40%
1 month3.80%-5.90%+9.70%
3 months-4.39%+22.35%-26.74%
6 months25.68%+28.74%-3.06%
1 year36.70%+9.15%+27.55%
3 years10.00%+9.02%+0.98%
5 years7.96%+17.33%-9.37%
10 years19.23%+8.17%+11.05%
Since inception9.12%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
Regeneron Pharmaceuticals IncUSA7.71%
Amgen IncUSA7.33%
Biogen IncUSA5.74%
Vertex Pharmaceuticals IncUSA4.53%
Alexion Pharmaceuticals IncUSA4.45%
Gilead Sciences IncUSA4.27%
Seattle Genetics IncUSA4.15%
Incyte CorpUSA3.32%
Biomarin Pharmaceutical IncUSA3.25%
Illumina IncUSA3.10%

Currently unavailable